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Dengue fever is a noncontagious infectious disease caused by dengue virus (DENV). DENV belongs to the family Flaviviridae,
genus Flavivirus, and is classified into four antigenically distinct serotypes: DENV-1, DENV-2, DENV-3, andDENV-4. The number
of nations and people aﬀected has increased steadily and today is considered the most widely spread arbovirus (arthropod-borne
viral disease) in the world. The absence of an appropriate animal model for studying the disease has hindered the understanding of
dengue pathogenesis. In our study, we have found that immunocompetent C57BL/6 mice infected intraperitoneally with DENV-1
presented some signs of dengue disease such as thrombocytopenia, spleen hemorrhage, liver damage, and increase in production
of IFNγ and TNFα cytokines. Moreover, the animals became viremic and the virus was detected in several organs by real-time
RT-PCR. Thus, this animal model could be used to study mechanism of dengue virus infection, to test antiviral drugs, as well as to
evaluate candidate vaccines.
1. Introduction
Dengue is a noncontagious infectious disease caused by
dengue virus (DENV), which is a positive-sense, single-
stranded RNA virus that belongs to the family Flaviviridae,
genus Flavivirus. DENV is classified into four antigenically
distinct serotypes: DENV-1, DENV-2, DENV-3, and DENV-
4 [1–3]. The number of nations and people aﬀected has
increased steadily and today is considered the most widely
spread arbovirus (arthropod-borne viral disease) in the
world. An estimated 50 million dengue infections occur
annually and approximately 2.5 billion people live in dengue
endemic countries [4]. Dengue can be presented in three
main clinical forms: undiﬀerentiated febrile illness, dengue
fever (DF), and dengue hemorrhagic fever (DHF) with or
without shock syndrome known as dengue shock syndrome
(DSS). The DF is presented as a self-limiting acute febrile
illness that lasts for about 4 to 5 days. The disease begins
abruptly with high fever, retroorbital pain, headaches of
varying degrees, maculopapular rash, muscle and joint aches,
and can also be observed mild hemorrhagic phenomena. In
DHF/DSS, in addition to the initial symptoms corresponding
to DF, between the second and fourth days of infection, there
is an increased thrombocytopenia and bleeding phenomena,
abdominal pain, and leakage of fluid into the interstitium,
which can lead to decrease intravascular plasma volume and
consequent hypovolemic shock that in some cases could be
fatal [5].
The absence of an appropriate animal model for studying
the disease has hindered the understanding of dengue
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pathogenesis. Several studies using immunocompetent, im-
munocompromised and humanized mice have been devel-
oped to analyze various aspects of the disease [6–12]. These
experimental models are useful according to the variable of
the disease to be evaluated.
The main objective of our study was to evaluate the
C57BL/6 mice as a model of dengue virus infection.
2. Material andMethod
2.1. Mice. Three-to-four-week-old C57BL/6 mice were
obtained from the Central Animal Facility at the University
of Sao Paulo/Ribeirao Preto and housed in specific pathogen
free (SPF) conditions at the Research Center of Virology,
Medical School of Ribeirao Preto (FMRP). All the procedures
were approved by the Animal Ethics Committee of the FMRP
(Protocol: 103/2005).
2.2. Virus. DENV-1, Mochizuki strain, was used in this
study. The virus was maintained in C6/36 cells culture at
28◦C for 7 days. Then, the virus was propagated in newborn
(1 to 2 days old) Swiss mice, by intracerebral inoculation of
infected cell culture supernatant. After the first appearance of
signs of paralysis, mice were sacrificed and stored at −70◦C
until use. The brains of infected and uninfected animals were
removed with sterile syringes and prepared as a suspension of
20%, using PBS containing 4% bovine fetal serum. The brain
was then macerated and the suspension was centrifuged at
10,000×g for five minutes. The supernatant was aliquoted
and stored at −70◦C. The viral title was determined by the
plaque assay [6].
2.3. Animal Infection and Sample Processing. The animals
were infected intraperitoneally with 150 μL viral suspension
containing 7.2 × 107 PFU or 150 μL of uninfected brains
suspension. At diﬀerent times postinfection, the blood was
obtained from the retroorbital region and collected in a
tube containing sodium citrate (3.8%) as an anticoagulant
in an amount corresponding to 10% of the total volume;
then, the animals were sacrificed to remove liver, brain,
spleen and kidney. The blood was centrifuged at 1000×g
for five minutes to obtain the plasma. The whole organs
were suspended in 500mL of PBS and ground in a tissue
homogenizer, except liver that only the right lobe was used.
The suspension was centrifuged at 8000×g for five minutes
and the supernatant was stored at −70◦C until use for viral
load quantification. Liver and brain of four mice were fixed
in 4% neutral formalin solution, embedded in paraﬃn, and
sectioned at a thickness of 3 μm. After deparaﬃnization
and rehydration, the sections were stained with hematoxylin
and eosin (H&E). The sections were then dehydrated before
mounting. The total number of nucleated cells was counted
in fifty microscopic fields in at least four representative,
nonconsecutive, HE-stained sections from each mouse.
Sections were examined using a Zeiss Integrationsplatte II
eyepiece (Zeiss Co, Oberkochen, Germany) reticule, using
a microscope at a final magnification of 400x. For hepatic
steatosis observation; liver of four mice was embedded in
Tissue-Teck OCT (Sakura Finetek, USA) and snap frozen in
isopentane cooled in liquid nitrogen and stored at −80◦C.
Cryosections of 5 μm thickness were mounted on a glass
slide, fixed in acetone for 5 minutes and stained with
hematoxylin and Sudan III.
2.4. Viral Quantification. The RNA was purified from 140 μL
of plasma or supernatant of the organs suspensions using the
QIAamp Viral RNA Mini Kit (QIAGEN, Germany) accord-
ing to the protocol recommended by the manufacturer. The
viral RNA was eluted with 80 μL of distilled water free of
DNase/RNase and stored at −70◦C. The real-time RT-PCR
was carried out as described previously [7]. A standard curve
was constructed using a decimal serial dilution of RNA
obtained form the viral seed (4.8 × 108 PFU/mL). The viral
title in plasma/organs was expressed as PFU/mL.
2.5. Hematocrit. The blood was collected into tubes contain-
ing anticoagulant and transferred to a capillary microhemat-
ocrit (Perfecta, Brazil). The capillaries were centrifuged for 5
minutes at 10,000×g in a microcentrifuge (Quimis, Brazil).
The analysis was performed according to manufacturer’s
recommendation.
2.6. Platelets. Platelet count was determined by the method
of Brecher and Cronkite [13].
2.7. Liver Enzymes. Oxaloacetic transaminase (AST) and
pyruvic transaminase (ALT) levels weremeasured in the plas-
ma of infected and not infected mice by specific biochemical
test (Labtest, Brazil) using Kinetic UV-IFCC methodology,
according to the manufacturer’s recommendations.
2.8. Spleen Cells Identification. The spleen of each mouse
was removed and placed in a small petri dish containing
3mL of sterile incomplete RPMI culture medium, on ice.
Then, the organ was macerated to obtain a cell suspension,
which was centrifuged at 1000×g for 10min at 4◦C. The
supernatant was discarded and the pellet was suspended in
4mL of erythrocyte lysis buﬀer ACK (0,15M of NH4Cl,
KHCO3, and 0,1mM of EDTA) and incubated at room
temperature for 4 minutes. Then, 6mL of complete RPMI
(with 10% of fetal bovine serum) was added to the cells
suspension and centrifuged at 1000×g for 10min at 4◦C.
The supernatant was discarded and cells were suspended in
1mL of complete RPMI medium for subsequent counting
in a Neubauer chamber. Aliquots of 100 μL of suspension
containing 1 × 106 spleen cells were incubated with 100 μL
of 5% rabbit serum for 40 minutes to minimize the
possibility of unspecific binding of monoclonal antibodies
(to block Fc and non-specific Ig binding sites) to cell surface
molecules. Then, samples were incubated with 1 μL of surface
markers monoclonal antibodies (anti-CD3, anti-CD4, anti-
CD8, anti-CD11b, anti-CD11c, anti-CD25, and anti-CTLA-
4) or isotype controls (IgG1-FITC, IgG2a-PE, IgG1-IgG1-
PerCP, and IgG2a-APC) directly conjugated to FITC, PE,
PerCP, and/or APC fluorochromes (Becton-Dickinson, USA,
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Figure 1: Viral load determined by real time RT-PCR in liver, spleen, kidney, serum (a), and brain (b) of infected animals.
or PharMingen, USA) for 30 minutes at room temperature,
in the dark. The cells were centrifuged for 5 minutes
at 1000×g, washed twice with PBS, suspended in 200 μL
of PBS, and analyzed immediately on the FACSort flow
cytometer (Becton-Dickinson, USA), acquiring a minimum
of 100,000 events. Two or three antibodies were used at
the same time to mark the cellular subpopulations of the
spleen. The following subcell populations present in the
spleen were analyzed: CD3+ (T lymphocytes), CD3+ CD4+
(T helper cells), CD3+ CD8+ (cytotoxic T cells), CD11c−
CD11b+ (macrophages), CD11c+ CD11b− (dendritic cells),
and CD4+ CD25+ CTLA-4+ (regulatory T cells).
2.9. Spleen Cell Culture for Detection of Intracellular Cytokines.
The spleen of each animal was macerated and the cells
suspension was adjusted to 5 × 106 spleen cells/mL
with RPMI 1640 containing 10% FBS. This suspension
was incubated at 37◦C for 48 hours. Then, PMA (10–
50 ng/mL) and ionomicyn (100–500 ng/mL) were added and
the suspension was vortexed. The cells were centrifuged at
1000×g for five minutes and then washed with cold PBS.
The cells were incubated with 0.5 μg of anti-CD16/CD32
mAb (FC receptor blocking) at 4◦C for 30 minutes and
then 0.5 μg of FITC-or PerCP labeled anti-CD3, CD4, and
CD8 (BD PharMingen, San Diego, CA, USA) were added
and incubated for 30min at 4◦C in the dark. For the
detection of intracellular IL-17, IL-10, TNF-α, and IFN-
γ cytokines, the subpopulation of CD4 cells was fixed
and permeabilize using Cytofix/Cytoperm (BD Biosciences,
USA), following manufacturer’s recommendations. Then,
the cells were washed and incubated with anti-IL-17, anti-
IL-10, anti-TNF-α, and anti-IFN-γ conjugated with FITC-,
APC-, or PE-fluorochromes, overnight at 4◦C in the dark.
Then, the cells were washed twice in 200mL of PBS with
1% formaldehyde and resuspended in the same solution.
The cells were immediately analyzed on the FACSort flow
cytometer (Becton-Dickinson, USA), acquiring a minimum
of 50,000 events, and then the data were analyzed using
FlowJo software.
2.10. Quantification of SerumCytokines. Serum samples were
added to tubes containing 50mg/mL a protease inhibitor
cocktail in PBS (Complete, Roche, USA). The samples
were centrifuged and the supernatant collected for cytokine
quantification. The level of cytokines (IL-10, IFN-γ, and
TNF-α) in serum was measured using an ELISA kit (R&D,
Minneapolis, MN, USA) and procedures were in accordance
with manufacturers’ specifications. The optical density was
measured at 450 nm. The results were expressed in picograms
per milliliter (pg/mL).
3. Results
3.1. Viral Detection. To analyze whether the mice were sus-
ceptible to infection, 24 animals were inoculated intraperi-
toneally with DENV-1. A group of 4 animals were sacrificed
2, 4, 7, 10, 16, and 21 days after infection for viral load
determination in serum, brain, liver, kidney, and spleen.
Viral RNA was detected by real-time RT-PCR from the
second to the sixteenth day after infection in blood and all
analyzed organs (Figure 1). A higher viral load was observed
in blood and brain, with a peak on the tenth day after viral
infection. These results showed that DENV-1 (Mochizuki
strain) inoculated intraperitoneally, established viremia, and
disseminated to various organs.
3.2. Platelets and Hematocrit. To analyze the platelets and
hematocrit after infection, blood sample from the retroor-
bital region of five mice was obtained 2, 4, 7, 10, 16, and
21 days after infection. The infected mice showed significant
reduction of platelet count between seven and ten days
after infection, and subsequently the platelet count return to
normal levels (Figure 2).
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Figure 2: Number of platelets in C57BL/6 along the infection
DENV1. The data were analyzed using the Student’s t-test and
diﬀerences were considered significant when P < 0.05 (∗).
The hematocrit was determined to evaluate the plasma
leakage into the interstitium; however, no diﬀerence in the
hematocrit between control and infected mice was observed
(Figure 3).
3.3. Analysis of Liver Damage and Cellular Infiltration. To
investigate any liver damage induced by infection, oxaloacetic
(AST), and pyruvic transaminase (ALT) enzymes were
measured in plasma. An increase level of both enzymes was
observed after infection, reaching a maximum concentration
on day 12 after infection, with a recovered of normal levels
on day 18 after infection (Figure 4).
To further analyze the presence of liver damage, five
animals were sacrificed nine days after infection and the
presence of steatosis in the liver was qualitatively evaluated.
Figure 5 shows the presence of microesteatose in the liver
of infected mice, suggesting a metabolic liver disorder.
In addition, the presence of inflammatory infiltrate of
mononuclear lymphocytes was also observed.
To further investigate the presence of cellular infiltrate
in the liver, the animals were infected and 0, 2, 4, 7, 10, 16,
and 21 after infection a histological analysis of the liver was
carried out. The analysis of the slides showed the presence of
cellular infiltrate in the liver, with a significant increase ten
days after infection (Figures 6 and 7).
3.4. Analysis of Cellular Infiltration in the Brain. To inves-
tigate the presence of cellular infiltrate in the of brain of
infected mice, the animals were sacrificed 2, 4, 7, 10, 16, and
21 days after infection to carry out histological analysis. The
analysis of the slides showed no cellular infiltration in the
brain (Figures 8 and 9).
3.5. Morphological Analysis of Spleen. For analysis of splenic
injury, we conducted a morphological analysis and found
hemorrhagic spleens in the infected mice (Figure 10).
3.6. Spleen Cellular Profile. The phenotype of immune cells
in the spleen was investigated by flow cytometry analysis on
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Figure 3: Hematocrit levels of C57BL/6 infected with DENV-1 and
uninfected control animals.
days 3, 6, and 9 after infection (Figure 11). No significant
increase of the number of CD4+ and CD8+ T lymphocytes
and dendritic cells was observed in the animals in any day
after infection when compared to the uninfected animal.
However, an increase in the population of macrophage
(CD11c− CD11b+ phenotype) cells was observed in the
infected animals three days after infection. Were also deter-
mined the percentage of regulatory T cells CD4+ CD25hi
which showed similar levels between infected and uninfected
mice, but this population of cells was an apparent decrease in
the expression of CTLA4 on the third day of infection.
3.7. Spleen Intralymphocyte CD4+ Cytokines Profile. Lym-
phocyte T CD4+ cells of infected animals showed a sig-
nificant production of IL-10, TNF-α, and IFN-γ cytokines
when compared to uninfected animals (Figure 12). On the
other hand, no diﬀerence was observed between infected and
uninfected animals in the production of IL-17.
3.8. Cytokine Profile by ELISA in Serum. Four animals were
sacrificed 2, 4, 7, 10, 16, and 21 days after infection to obtain
the serum for cytokines quantification (TNF, IFNγ, and IL-
10). The infected animals showed a significant increase in
production of TNFα and IFNγ compared to the uninfected
animals, but no diﬀerence was observed between them in the
production of IL-10 (Figure 13).
4. Discussion
Symptoms and signs of dengue fever include sudden onset
of high fever, retroorbital headache, rash, joint and muscle
pain, some degree of hemorrhage, low platelet counts and
liver damage. Several immunodeficient animal models have
been described to study diﬀerent aspects of the disease
[7, 9, 10, 14]. Several animal models have been used
to study the disease, including immunocompetent [6, 8]
immunocompromised [7, 9] and humanized mice [15].
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Figure 4: AST (a) and ALT (b) levels in infected and uninfected C57BL/6. Data were analyzed using the Student’s t-test and diﬀerences were
considered significant when P < 0.05 (∗).
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Figure 5: Histology of liver of C57BL/6 on the ninth day of infection with DENV-1 (a). Liver of noninfected mice, showing normal aspect;
(b) and (c). Infected mouse liver, showing fat accumulation; (d). Infected mouse liver, showing inflammatory infiltrate. Hematoxylin and
Sudan III. The magnification was 400x.
However, it is well known that the immune system
combats an invading pathogen by a very complex interplay
between the many diﬀerent components of this system;
thus, important interplay between those components can be
masked by the immunodeficiency induced in those animals,
leading, in some cases, to misleading conclusions. In this
study, we have established an experimental model of DENV
infection using immunocompetent C57BL/6 mice, which
showed some signs of DF similar to those observed in
human. Moreover, the animals became viremic and the virus
spread to several organs.
Approximately, one-third of DF patients may have mild
hemorrhage manifestations, which may be related to the low
platelet count [5]. Then, platelet count is a useful marker to
be evaluated in an animal model during DENV infection.
In that sense, our C57BL/6 mice model showed a significant
thrombocytopenia between seven and ten days after DENV-
1 infection. In other studies, H. C. Chen, (2007), and
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Figure 6: Histology of liver of uninfected mice (a); seven days after infection (b) and 10 days after infection (c). The arrows indicate the
presence of cellular infiltrate. Eosin and Hematoxylin staining. The magnification was 200x.
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Figure 7: Count of liver nuclei of mice infected with DENV-1. The data were analyzed using the Student’s t-test and diﬀerences were
considered significant when P < 0.05 (∗).
Y. T. Yen, (2008), have also shown that C57BL/6mice infected
with DENV-2 showed a significant thrombocytopenia and
severe systemic hemorrhage when a very high viral dose (2×
109 PFU) was used for the infection, but no hemorrhage was
observed at lower viral dose (4 × 107 PFU). In our study, we
did not analyze in more details the presence of hemorrhage,
but macroscopic hemorrhage was observed in the spleen of
the infected animals.
After the mosquito biting, human skin dendritic cells
(Langerhans cells) are one of the first targets for DENV
infection [15–18]. Then, the virus spread systemically infect-
ing several organs. In that sense, DENV has been found in
The Scientific World Journal 7
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Figure 8: Histology of the animal brains. Uninfected mice (a); mice after seven days of infection (b), and mice after ten days after infection
(c). Eosin and hematoxylin staining. The magnification was 200x.
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Figure 9: Count of brain nuclei of mice infected with DENV-1. The data not demonstrated a statistically significant diﬀerence.
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Figure 10: Macroscopic observation of the spleen from uninfected C57BL/6 mice (a), infected and collected 2 (b) and 7 days after infection
(c). The arrows indicate points of hemorrhage.
diﬀerent organs such as skin [19], liver [20–22], spleen [21–
23], lymph nodes [21, 22], kidney [22, 24], bone marrow
[22, 24], lung [22, 24], thymus [25], and brain [26]. The
animal model analyzed in our study showed the presence
of viral genome in kidney, liver, spleen and brain after
infection. Although liver is not a major target organ, several
studies have demonstrated elevated liver enzyme levels in
human serum indicating the damage of this organ after
DENV infection [27–30]. Hepatitis associated with dengue
fever is also characterized by moderate hepatocytes necrosis,
microvesicular steatosis and cellular infiltration [31–33].
The C57BL/6 mice analyzed in this study presented high
concentration of serum transaminases, liver inflammatory
infiltration, and steatosis showing the injury induced by viral
infection. H. C. Chen and colleagues have also observed
liver damage using the same animal model; however, they
infected the animals with a viral dose of 1 × 108 PFU,
while in our study we have used a lower viral dose (7.2 ×
107 PFU), which is easier to manage in the laboratory [6].
In addition, they used an intravenous route of infection
instead of the intraperitoneal route used in our study. DENV
infection of animals by peripheral inoculation, such as the
intraperitoneal route, has been shown to reproduce some
aspect of human disease [8, 12, 34]. The intraperitoneal route
can also facilitate the infection of macrophage, which is one
of the initial targets of DENV infection [35]. Other studies
using BALB/c as animal model have found also liver damage;
however, the virus was not detected in serum or detected only
after serum inoculation in cell culture [36, 37].
One of the main components of the immune system
against DENV infection includes interferons (IFNs) from
the Th1 cytokine profile [38–40]. Shresta and colleagues
have shown that AG129 mice lacking both IFN-α/β and
IFN-γ receptors are completely susceptible to DEN2-induced
disease, showing that these cytokines have critical function
resolving DENV infection [41]. H. C. Chen and colleagues
have found that C57BL/6 infected with 1 × 108 PFU of
DENV-2 strain 16681 showed a significant increase of CD4+
and CD8+ T cells count and production of IFNγ [6]. In our
study, although no increase of CD4+ and CD8+ T cells count
was observed, a significant increase of IFNγ, with peak on
day 10 after infection, was observed infecting the animals
with DENV-1 strainMochizuki with a lower viral dose (7.2×
107 PFU).
TNF-α has been recognized as an important factor for
the development of the severe dengue disease [42–44].
C57BL/6 mice have been established as a dengue hemorrhage
model and found that TNF-α is a very important cytokine
that induces endothelial damage and hemorrhage [7, 45].
These authors used an extremely high viral dose (2 ×
109 PFU) to induce systemic hemorrhage and only local
subcutaneous hemorrhage when they used a lower viral dose
(8 × 107 PFU). Although we did not analyze the hemorrhage
in more details, mice infected with a lower viral dose (7.2 ×
107 PFU) showed spleen hemorrhage, suggesting a systemic
injury.
IL-10 is an important component of the Th2 cytokine
profile that contains and suppresses inflammatory responses
[46, 47]. In our study, we have found an increase of spleen
CD4+ T lymphocytes producing IL-10 seven days after
infection, in addition to the IFNγ and TNF-α producing
cells. However, no diﬀerence in the serum concentration
of IL-10 was found when compared to the uninfected
animals, in contrast to the increase concentration of IFNγ
and TNF-α (Figure 13). This discrepancy can be related to
the low number of IL-10 producing cells observed in the
spleen when compared to the IFNγ and TNF-α producing
cells. In addition, the identification of IL-10 producing cells
was observed by in vitro polyclonal stimulation and not
necessarily reflects the serum concentration.
Several studies have been demonstrated that spleen cells
are target of infection with DENV in humans and mice [21,
22]. Basilio deOliveira and colleagues showed in a case report
that spleen was grossly congested with multiple hemorrhagic
foci [21]. We found diﬀerence in the size between spleens of
infected and uninfected mice and hemorrhagic foci at days 2
and 7 after infection.
In summary, we have found that C57BL/6 mice infected
intraperitoneally with DENV-1 presented some signs of
dengue disease such as thrombocytopenia, hemorrhage,
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Figure 11: Percentage of CD4+ (a), CD8+ (b), dendritic cells (c), macrophages (d), and regulatory T cells ((e) and (f)) from the spleen in
the third, sixth, and ninth days of infection with DENV1. The data were analyzed using the Student’s t-test and diﬀerences were considered
significant when P < 0.05 (∗).
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diﬀerence at days 4, 7, 10, and 16, and (c) IL-10 not demonstrated a statistically significant diﬀerence. The data were analyzed using the
Student’s t-test and diﬀerences were considered significant when P < 0.05 (∗).
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liver damage, and increase production of IFNγ and TNFα
cytokines. Thus, this animal model could be used to study
dengue virus infection, to test antiviral drugs as well as to
candidate vaccines.
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